Related Experiment Video
Updated: Jul 12, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetic heterogeneity of cardiomyopathy and its correlation with patient care
Mi Jin Kim1, Seulgi Cha1, Jae Suk Baek1
1Division of Pediatric Cardiology, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Insights
Genetic testing identified diverse cardiomyopathy genotypes in Korean patients, aiding personalized management. Specific gene variants like TTN and MYH7 were common in dilated and hypertrophic cardiomyopathy, respectively.
Area of Science:
- Genetics
- Cardiology
- Genomic Medicine
Background:
- Cardiomyopathy is a heterogeneous heart condition with significant morbidity and mortality.
- Genetic diagnosis is crucial for accurate classification, management, and counseling of cardiomyopathy patients.
Purpose of the Study:
- To investigate the genetic spectrum of cardiomyopathy in a Korean population.
- To correlate genetic findings with the clinical course and outcomes of cardiomyopathy.
Main Methods:
- Whole-exome sequencing (WES) was performed on 72 Korean patients with cardiomyopathy.
- Familial information and clinical characteristics were analyzed alongside genotypic data.
Main Results:
- Dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) were the most prevalent types.
- Genetic variants were identified in 51.4% of patients, with TTN and MYH7 being common in DCM and HCM, respectively.
- LMNA variants in DCM were associated with worse outcomes compared to TTN or MYH7 variants.
Conclusions:
- A substantial proportion of cardiomyopathy patients harbor diverse genetic mutations.
- Genetic diagnosis facilitates personalized disease surveillance and management strategies.
Background:
Cardiomyopathy, which is a genetically and phenotypically heterogeneous pathological condition, is associated with increased morbidity and mortality. Genetic diagnosis of cardiomyopathy enables accurate phenotypic classification and optimum patient management and counseling. This study investigated the genetic spectrum of cardiomyopathy and its correlation with the clinical course of the disease.
Methods:
The samples of 72 Korean patients with cardiomyopathy (43 males and 29 females) were subjected to whole-exome sequencing (WES). The familial information and clinical characteristics of the patients were reviewed and analyzed according to their genotypes.
Results:
Dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), left ventricular non-compaction cardiomyopathy, and restrictive cardiomyopathy was detected in 41 (56.9%), 25 (34.7%), 4 (5.6%), and 2 (2.8%) patients, respectively. WES analysis revealed positive results in 37 (51.4%) patients. Subsequent familial testing identified ten additional familial cases. Among DCM cases, 19 (46.3%) patients exhibited positive results, with TTN variants being the most common alteration, followed by LMNA and MYH7 variants. Meanwhile, among HCM cases, 15 (60%) patients exhibited positive results with MYH7 variants being the most common alteration. In six patients with positive results, extracardiac surveillance was warranted based on disease information. The incidence of worse outcomes, such as mortality and life-threatening arrhythmic events, in patients with DCM harboring LMNA variants, was higher than that in patients with DCM harboring TTN or MYH7 variants.
Conclusions:
Diverse genotypes were identified in a substantial proportion of patients with cardiomyopathy. Genetic diagnosis enables personalized disease surveillance and management.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management

